 |
Prospector
Profile
07.1588
|
| |
| Biofield Corp. |
NAICS |
334510 |
| King of Prussia Business Center, 1019 West Ninth Avenue
King of Prussia, PA 19406 |
Description |
Medical Equipment Mfg. |
| (215) 972-1717 |
Employees |
3 |
| http://www.biofield.com/ |
Revenue |
(mil) |
0.0000 |
| |
Income |
(mil) |
-0.8090 |
| |
Assets |
(mil) |
0.0110 |
| |
Liability |
(mil) |
6.5060 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Default
|
| |
|
Event:
During 2006, Biofield Corp. issued notes totaling $110,000 for past due obligations. These notes bear interest at 18% through the maximum amount allowed by law. These notes were due at various dates during 2006 and 2007 and are in default. The Company is currently working with the holders of these notes to resolve the defaults.
|
| |
|
Intellectual Property:
On July 27, 2007, Biofield Corp. signed a master license agreement with MacKay Group Limited. Pursuant to the Agreement, the Company granted to MacKay Group an exclusive sub-licensable, royalty-bearing, worldwide license to make and sell devices, sensors and other products or services incorporating the Company's patented and unpatented breast cancer detection technology, including the Biofield Diagnostic System, the Biofield Breast Cancer Proliferation Detection System, the Breast Cancer Diagnostic Device, and the Biofield Breast Examination. The Company also granted MacKay Group, on a worldwide basis, the exclusive distribution, manufacturing, development, clinical and R&D rights to the technology. [SEC Filing 10-KSB 10-22-07]
|
| |
|
Description:
The Company engages in the development and provision of medical device and associated diagnostic system to assist in detecting breast cancer.
|
| |
|
Officers:
James MacKay (Chair); Michael Antonoplos (CEO & Dir.); Kenny Lau (Dir.); Michael Yom (COO & Dir.); Joseph Repko (CFO)
|
| |
|
Auditor:
Jewett Schwartz Wolfe & Associates
|
| |
|
Securities:
Common Stock-Symbol BZET.PK; Other OTC;
53,137,486 common shares outstanding as of October 22, 2007.
|
| |
| |
| |
| return to main page |
|
|
